EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling

Fabienne Briand-Mésange, Isabelle Gennero, Juliette Salles iD, Stéphanie Trudel, Lionel Dahan iD, Jérôme Ausseil, Bernard Payrastre iD, Jean-Pierre Salles iD, Hugues Chap iD

Molecules · 04.08.2024 · 29 (15) · 3694

DOI: 10.3390/molecules29153694 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 04.08.2024. Verfasst von Fabienne Briand-Mésange und 8 weiteren Autor:innen. Beteiligte Einrichtung: Infinity-Toulouse Institute for Infectious and Inflammatory Diseases, University of Toulouse, INSERM, CNRS, Paul Sabatier University, 31059 Toulouse,…. Hauptthemen laut MEDLINE: Endocannabinoids, Glycerides, Lysophospholipids, Arachidonic Acids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 517 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Cancéropôle Grand Sud-Ouest, Université Toulouse III - Paul Sabatier.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

2-arachidonoylglycerol (2-AG) is the most abundant endocannabinoid (EC), acting as a full agonist at both CB1 and CB2 cannabinoid receptors. It is synthesized on demand in postsynaptic membranes through the sequential action of phosphoinositide-specific phospholipase Cβ1 (PLCβ1) and diacylglycerol lipase α (DAGLα), contributing to retrograde signaling upon interaction with presynaptic CB1. However, 2-AG production might also involve various combinations of PLC and DAGL isoforms, as well as additional intracellular pathways implying other enzymes and substrates. Three other alternative pathways of 2-AG synthesis rest on the extracellular cleavage of 2-arachidonoyl-lysophospholipids by three different hydrolases: glycerophosphodiesterase 3 (GDE3), lipid phosphate phosphatases (LPPs), and two members of ecto-nucleotide pyrophosphatase/phosphodiesterases (ENPP6–7). We propose the names of AlterAG-1, -2, and -3 for three pathways sharing an ectocellular localization, allowing them to convert extracellular lysophospholipid mediators into 2-AG, thus inducing typical signaling switches between various G-protein-coupled receptors (GPCRs). This implies the critical importance of the regioisomerism of both lysophospholipid (LPLs) and 2-AG, which is the object of deep analysis within this review. The precise functional roles of AlterAGs are still poorly understood and will require gene invalidation approaches, knowing that both 2-AG and its related lysophospholipids are involved in numerous aspects of physiology and pathology, including cancer, inflammation, immune defenses, obesity, bone development, neurodegeneration, or psychiatric disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsGlyceridesLysophospholipidsArachidonic AcidsSignal TransductionHumansAnimalsPhosphoric Diester Hydrolases

Stichwörter der Autor:innen

2-arachidonoylglycerolENPPGDE3autotaxinendocannabinoidslipid phosphate phosphataseslysophosphatidic acidlysophosphatidylcholinelysophosphatidylinositollysophosphatidylserineplasticity-related-gene 1

Substanzen

Endocannabinoidsglyceryl 2-arachidonateGlyceridesLysophospholipidsArachidonic AcidsPhosphoric Diester Hydrolases

Autor:innen und Institutionen

  • Infinity-Toulouse Institute for Infectious and Inflammatory Diseases, University of Toulouse, INSERM, CNRS, Paul Sabatier University, 31059 Toulouse, France.
  • Centre Hospitalier Universitaire de Toulouse, Service de Biochimie, Institut Fédératif de Biologie, 31059 Toulouse, France.
  • Centre Hospitalier Universitaire de Toulouse, Service de Psychiatrie D'urgences, de Crise et de Liaison, Institut des Handicaps Neurologiques, Psychiatriques et Sensoriels, 31059 Toulouse, France.
  • Centre de Recherches sur la Cognition Animale (CRCA), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, 31062 Toulouse, France.
  • I2MC-Institute of Metabolic and Cardiovascular Diseases, INSERM UMR1297 and University of Toulouse III, 31400 Toulouse, France.
  • Centre Hospitalier Universitaire de Toulouse, Laboratoire d'Hématologie, 31400 Toulouse, France.

ORCID-Profile: Juliette Salles, Lionel Dahan, Bernard Payrastre, Jean-Pierre Salles, Hugues Chap

Förderung

  • Agence Nationale de la Recherche
  • Cancéropôle Grand Sud-Ouest
  • Université Toulouse III - Paul Sabatier
  • La Ligue Contre le Cancer
  • Cancéropôle du Grand-Sud-Ouest
  • Université Toulouse III (Paul Sabatier)
  • Ligue Nationale contre le Cancer 31

Zitieren

APA

Briand-Mésange, F., Gennero, I., Salles, J., Trudel, S., Dahan, L., Ausseil, J., Payrastre, B., Salles, J. P., & Chap, H. (2024). From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling. Molecules, 29(15), 3694. https://doi.org/10.3390/molecules29153694

Vancouver

Briand-Mésange F, Gennero I, Salles J, Trudel S, Dahan L, Ausseil J, et al. From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling. Molecules. 2024;29(15):3694. doi:10.3390/molecules29153694

BibTeX
@article{BriandMsange2024,
  author = {Briand-Mésange, Fabienne and Gennero, Isabelle and Salles, Juliette and Trudel, Stéphanie and Dahan, Lionel and Ausseil, Jérôme and Payrastre, Bernard and Salles, Jean-Pierre and Chap, Hugues},
  title = {From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {15},
  pages = {3694},
  doi = {10.3390/molecules29153694}
}
Kostenlos starten →